PROTEOMICS INTERNATIONAL LABORATORIES LIMITED

Highlights Proteomics International Laboratories Limited

Equities

PIQ

AU000000PIQ0

Market Closed - Australian S.E. Other stock markets 01:59:14 2024-05-09 EDT			5-day change	1st Jan Change
1.03 ^AUD	-0.96%		-1.44%	+15.08%

03-25	Proteomics International Signs Agreement with University of Oxford for Endometriosis Study	MT
03-19	Proteomics Says PromarkerD's US Launch Delayed	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Proteomics International Signs Agreement with University of Oxford for Endometriosis Study	03-24	MT
Proteomics International Laboratories Narrows Fiscal H1 Loss	02-23	MT
Proteomics International Laboratories Limited Reports Earnings Results for the Half Year Ended December 31, 2023	02-22	CI
Proteomics International Laboratories Receives More than AU$1.8 Million R&D Tax Rebate	11-08	MT
Proteomics International Subsidiary Secures New Patent in Japan; Shares Fall 4%	23-09-03	MT
Proteomics International Laboratories Limited Reports Earnings Results for the Full Year Ended June 30, 2023	23-08-21	CI
Proteomics International Laboratories Signs Deal to Commercialize Diagnostic Test in the US; Shares Rally 11%	23-05-09	MT
Proteomics International Laboratories to Resubmit Medicare Application for Diagnostic Test in Australia	23-03-15	MT
Proteomics International Laboratories Limited Announces to Resubmit Application for PromarkerD Listing on Australian Medicare Benefits Schedule	23-03-15	CI
Proteomics International Laboratories Limited Provides Update on Exclusive Licence Agreement with Sonic Healthcare USA, Inc	23-02-28	CI
Proteomics International Laboratories Limited Reports Earnings Results for the Half Year Ended December 31, 2022	23-02-26	CI
Proteomics International Laboratories Extends Predictive Test Distribution Agreement in Britain	23-02-15	MT
Proteomics International Laboratories Ltd Extends its Distribution Agreement with Apacor Limited to Bring its PromarkerD Predictive Test for Diabetic Kidney Disease to Patients in England, Scotland and Wales	23-02-14	CI
Proteomics International Laboratories Limited Announces Letter of Intent with Sonic Healthcare USA Extended	23-01-30	CI
Proteomics International Laboratories Applies for Quotation of 50,000 Shares	23-01-11	MT
Proteomics International Extends LOI for Proposed Licensing Deal With Sonic Healthcare's US Division	23-01-04	MT
Proteomics International Laboratories Ltd Extends Term of Its Letter of Intent with Sonic Healthcare USA	23-01-04	CI
Proteomics International Laboratories Secures Reimbursement Code in the US for Diagnostic Test; Shares Rise 5%	23-01-02	MT
Proteomics International Laboratories Ltd Announces the Achievement of a Major Milestone in the Commercialisation of the PromarkerD Predictive Test for Diabetic Kidney Disease with the Approval of a New Dedicated CPT Proprietary Laboratory Analyses Code for the Test in the United States	23-01-02	CI
Proteomics International Laboratories Secures Hong Kong Patent for Diabetes Test	22-11-10	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Proteomics International Laboratories Limited

Equities

PIQ

AU000000PIQ0

Highlights

Filters